Evidence map›Paper›PMID 37258639›Full record

ArticleScientific reports2023

Clustering of clinical and echocardiographic phenotypes of covid-19 patients.

Eran Shpigelman, Aviram Hochstadt, Dan Coster, Ilan Merdler, Eihab Ghantous, Yishay Szekely, Yael Lichter, Philippe Taieb, Ariel Banai, Orly Sapir and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Eran Shpigelman *The Blavatnik School of Computer Science, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel.
Aviram Hochstadt *Department of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Dan CosterThe Blavatnik School of Computer Science, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel.
Ilan MerdlerDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Eihab GhantousDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Yishay SzekelyDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Yael LichterDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Philippe TaiebDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Ariel BanaiDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Orly SapirDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Yoav GranotDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Lior LupuDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Ariel BorohovitzDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Sapir SadonDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Shmuel BanaiDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Ronen RubinshteinHeart Institute, Edith Wolfson Medical Center, Ha-Lokhamim St 62, 5822012, Holon, Israel.
Yan TopilskyDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Dafna St 5, Tel Aviv-Yafo, Israel.
Ron ShamirThe Blavatnik School of Computer Science, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel. rshamir@tau.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We sought to divide COVID-19 patients into distinct phenotypical subgroups using echocardiography and clinical markers to elucidate the pathogenesis of the disease and its heterogeneous cardiac involvement. A total of 506 consecutive patients hospitalized with COVID-19 infection underwent complete evaluation, including echocardiography, at admission. A k-prototypes algorithm applied to patients' clinical and imaging data at admission partitioned the patients into four phenotypical clusters: Clusters 0 and 1 were younger and healthier, 2 and 3 were older with worse cardiac indexes, and clusters 1 and 3 had a stronger inflammatory response. The clusters manifested very distinct survival patterns (C-index for the Cox proportional hazard model 0.77), with survival best for cluster 0, intermediate for 1-2 and worst for 3. Interestingly, cluster 1 showed a harsher disease course than cluster 2 but with similar survival. Clusters obtained with echocardiography were more predictive of mortality than clusters obtained without echocardiography. Additionally, several echocardiography variables (E' lat, E' sept, E/e average) showed high discriminative power among the clusters. The results suggested that older infected males have a higher chance to deteriorate than older infected females. In conclusion, COVID-19 manifests differently for distinctive clusters of patients. These clusters reflect different disease manifestations and prognoses. Although including echocardiography improved the predictive power, its marginal contribution over clustering using clinical parameters only does not justify the burden of echocardiography data collection.

Indexed as

COVID-19Cluster AnalysisEchocardiographyFemaleHumansMalePhenotypePrognosis

Identifiers

PMID37258639
PMCPMC10231284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.